Teosyal RHA 4 Puresense Lidocaine is a high-performance dermal filler designed for restoring significant volume and reshaping facial contours in dynamic areas. Based on advanced RHA (Resilient Hyaluronic Acid) technology, it provides strong lifting capacity while adapting naturally to facial movements. The addition of lidocaine enhances comfort during treatment. Intended for professional aesthetic use.
Key Ingredients
• Resilient Cross-linked Hyaluronic Acid (RHA): High elasticity and strength to restore volume and support while maintaining natural facial expressions.
• Lidocaine: Integrated local anesthetic to reduce discomfort during injection.
Benefits
• Restores significant volume loss.
• Enhances and reshapes facial contours.
• Maintains natural movement in highly dynamic areas.
• Provides long-lasting, natural-looking results.
• Improved patient comfort during treatment.
Indications
• Cheek and midface volume restoration
• Facial contouring and structural support
• Deep folds and volume deficiencies
• Dynamic areas requiring strong lift with flexibility
Usage
For professional use only. Injected into the deep dermis or subcutaneous tissue by trained medical practitioners. Injection technique and volume should be adapted to the patient’s anatomy and aesthetic goals.
Important Information
• Medical device for aesthetic use by qualified professionals only.
• Not suitable for patients with known hypersensitivity to hyaluronic acid or lidocaine.
• Temporary reactions such as redness, swelling, or bruising at the injection site may occur.
• Store according to manufacturer instructions, away from heat and direct light.
• CE-certified and manufactured in compliance with European medical device standards.
Packaging
2 prefilled syringes × 1.2 ml
Summary
Teosyal RHA 4 Puresense Lidocaine 2×1.2 ml is a professional dermal filler designed for advanced volume restoration and facial contouring. Its resilient hyaluronic acid technology delivers strong lift, durability, and natural facial movement with enhanced comfort during treatment.